Elevance Health Stock

$309.60

0.13% yesterday

NYSE, Aug 21, 10:10 pm CET

ISIN

US0367521038

Symbol

ELV

Reports

Quarter | Annual

Index

NYSE Composite, S&P 500

Sector

Health Care Equipment & Services

Industry

Health Care Providers & Services

Overview Dividends Analysts Charts News Strategies

Elevance Health Stock price

$309.60

+24.97 8.77% 5Y

NYSE, Closing price Thu, Aug 21 2025

-0.40 0.13%

ISIN

US0367521038

Symbol

ELV

Reports

Quarter | Annual

Index

NYSE Composite, S&P 500

Sector

Health Care Equipment & Services

Industry

Health Care Providers & Services

Key metrics

Basic

Market capitalization

$69.8b

Enterprise Value

$91.4b

Net debt

$21.6b

Cash

$8.6b

Shares outstanding

224.8m

Valuation (TTM | estimate)

P/E

13.1 | 8.9

P/S

0.4 | 0.4

EV/Sales

0.5 | 0.5

EV/FCF

17.3

P/B

1.6

Dividends

DPS

$6.52

Yield 1Y | 5Y

2.1% | 1.2%

Growth 1Y | 5Y

10.1% | 15.3%

Payout 1Y | 3Y

25.4% | 23.4%

Increased

14 Years

Financials (TTM | estimate)

Revenue

$189.3b | $198.6b

EBITDA

$9.3b | $10.6b

EBIT

$8.7b | $10.0b

Net Income

$5.4b | $7.8b

Free Cash Flow

$5.3b

Growth (TTM | estimate)

Revenue

10.2% | 12.3%

EBITDA

-14.3% | 8.5%

EBIT

-14.3% | 9.4%

Net Income

-19.9% | 30.7%

Free Cash Flow

562.3%

Financial Health

Equity Ratio

35.4%

Return on Equity

14.5%

ROCE

7.7%

ROIC

Debt/Equity

0.7

EPS

$23.7

FCF per Share

$23.5

Short interest

1.3%

Employees

104k

Rev per Employee

$1.7m

As a Free StocksGuide user, you can view scores for all 7,014 stocks worldwide.

Get Started for Free Today

Elevance Health Stock Analysis

Unlock Scores for Free

??

28 Analysts have issued a Elevance Health forecast:

18x Buy

64%

10x Hold

36%

More details on Analyst Estimates Including Price Targets

28 Analysts have issued a Elevance Health forecast:

Buy

64%

Hold

36%

Analyst Estimates with Stock Price Targets

Financial data from Elevance Health

Income Statement P&L | Balance Sheet | Cash Flow

Quarter TTM Annually

Jun '25		+/- %
Revenue	189,254 189,254	10% 10% 100%
- Direct Costs	- -	- -
Gross Profit	- -	- -
- Selling and Administrative Expenses	- -	- -
- Research and Development Expense	- -	- -
EBITDA	9,304 9,304	14% 14% 5%
- Depreciation and Amortization	604 604	15% 15% 0%
EBIT (Operating Income) EBIT	8,700 8,700	14% 14% 5%
Net Profit	5,360 5,360	20% 20% 3%

In millions USD.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

Subscribe Now

Elevance Health Stock News

Neutral

Seeking Alpha

●

about 6 hours ago

Elevance Health - Piggy Bank Or Headache?

Elevance and peers face earnings pressure from rising medical costs, driven by deferred care, expensive drugs, and persistent medical inflation. The segment has re-rated, and now offers good value. Investor sentiment has returned, and capital is rotating into healthcare.

Negative

Reuters

●

2 days ago

Elevance Health loses bid to challenge US Medicare star ratings

A federal judge in Texas on Tuesday rejected Elevance Health's challenge of the U.S. government's calculation for the health insurer's star ratings for some of its government-backed Medicare plans after the company said improper rounding cost it at least $375 million.

Neutral

Business Wire

●

4 days ago

Elevance Health and National Association of Community Health Centers Partnership Integrates Food as Medicine With Primary Care

INDIANAPOLIS--(BUSINESS WIRE)-- #ElevanceHealth--Elevance Health and the National Association of Community Health Centers (NACHC) are proud to announce the integration of Food as Medicine (FAM) programming with primary care Community Health Centers (CHCs). This milestone - built on a shared commitment to whole health and community-centered innovation - marks a transformative step forward in add...

More Elevance Health News

Company Profile

Elevance Health, Inc. operates as a health company, which engages in improving lives and communities, and making healthcare simpler. It operates through the following segments: Commercial and Specialty Business, Government Business, CarelonRx, and Other. The Commercial and Specialty Business segment provides insurance products and services such as stop loss, dental, vision, life, disability and supplemental health insurance. The Government Business segment includes medicare and medicaid businesses, national government services, and services provided to the federal government. The CerelonRx segment offers formulary management, pharmacy networks, prescription drug database, member services, and mail order capabilities. The Other segment is involved in health services business focused on quality of healthcare by enabling and creating new care delivery and payment models. The company was founded in 1944 and is headquartered in Indianapolis, IN.

Head office	United States
CEO	Gail Boudreaux
Employees	104,200
Founded	1944
Website	www.elevancehealth.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

Start now